-
-
-
-
-
-
-
Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States
-
-
-
-
-
-
-
Median Technologies Appoints Didric Cederholm to Its Board of Directors
-
-
-
-
-
-
-
Median Technologies Signs Financial Agreement for up to €37.5 Million New Financing Facility With the European Investment Bank (EIB)
-
-
-
-
-
-
-
Median Technologies to Showcase Its Artificial Intelligence Software as a Medical Device for Lung Cancer Screening, eyonis™ LCS, at the European Congress of Radiology
-
-
-
-
-
-
-
Median Technologies to share positive pivotal data for eyonis™ LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer
-
-
-
-
-
-
-
Median Technologies Reports Full-year 2022 Results and Business Indicators for the First Quarter Of 2023
-
-
-
-
-
-
-
Median Technologies' Business Continues to Grow at a Steady Pace in the First Half of 2021 (Unaudited Figures)
-
1,199,919 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

